Downloads
Revenue

Description

专注于慢性病的疗效管理,通过手机蓝牙与百慕迪“生物电”技术移动治疗终端R7相连接,有效提高用户的依从性,并为用户提供便捷的疗效管理服务。
百慕迪“生物电”技术是全球专利生物电“无创血管正常化”专利技术,能够有效促进体内血管修复再生、改善微循环障碍。根据报备上海食药监局的临床后研究报告显示,该技术对血管相关的慢性疾病具有独特的康复作用。通过上万例临床后试验统计数据表明,其对血管病变的无创修复有效率达到90%以上,并对心脏病、睡眠障碍、中风后遗症、静脉曲张等十余种与血管相关的慢性病,均达到60%-82%之间的不同程度改善(以上数据仅作为临床后统计研究,不作为临床有效证据),为慢性疾病的防治增添了一种极为安全、有效的康复途径。
【温馨提示】
健康:支持接入iphone健康数据,可通过百慕迪APP-健康查看个人的健康信息
蓝牙:如果百慕迪APP与R7设备已绑定,百慕迪APP会持续使用蓝牙功能确保与百慕迪R7设备连接,从中获取使用数据。APP切换到后台时,仍会保持蓝牙功能开启,相比其他操作会消耗更多的电量。
遇到问题请快速联系我们
邮箱:[email protected]
您可以直接在应用内““我的-意见反馈”中进行反馈,我们将及时处理您的问题
Hide Show More...

Screenshots

百慕迪 FAQ

  • Is 百慕迪 free?

    Yes, 百慕迪 is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is 百慕迪 legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does 百慕迪 cost?

    百慕迪 is free.

  • What is 百慕迪 revenue?

    To get estimated revenue of 百慕迪 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Spain yet.
Ratings History

百慕迪 Reviews

No Reviews in Spain
App doesn't have any reviews in Spain yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

百慕迪 Competitors

Name
优复医数医生
全自动化随访方案助您管理病患
云健康复
云康复
小乐医生
心脑血管医患交互平台
早早发现
山桔健康
倾听跑
竹信健康
AI ECG
村医邦
乡村医生基层服务平台
禅眠-科学睡眠管理APP

百慕迪 Installs

Last 30 days

百慕迪 Revenue

Last 30 days

百慕迪 Revenue and Downloads

Gain valuable insights into 百慕迪 performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Languages
English, Chinese
Recent release
3.1.0 (4 years ago )
Released on
Jan 22, 2017 (7 years ago )
Last Updated
1 month ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.